Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
46.02
-1.25 (-2.64%)
Mar 5, 2026, 4:00 PM EST - Market closed
KNSA Stock Forecast
Stock Price Forecast
The 7 analysts that cover KNSA stock have a consensus rating of "Strong Buy" and an average price target of $55.29, which forecasts a 20.14% increase in the stock price over the next year. The lowest target is $50 and the highest is $62.
Price Target: $55.29 (+20.14%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KNSA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 5 |
| Buy | 4 | 4 | 4 | 4 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $50 → $53 | Buy | Maintains | $50 → $53 | +15.17% | Feb 25, 2026 |
| Wedbush | Wedbush | Buy Maintains $50 → $53 | Buy | Maintains | $50 → $53 | +15.17% | Feb 25, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $62 | Strong Buy | Initiates | $62 | +34.72% | Feb 19, 2026 |
| Wedbush | Wedbush | Buy Maintains $48 → $50 | Buy | Maintains | $48 → $50 | +8.65% | Jan 13, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $45 → $55 | Strong Buy | Maintains | $45 → $55 | +19.51% | Oct 29, 2025 |
Financial Forecast
Revenue This Year
935.11M
from 677.56M
Increased by 38.01%
Revenue Next Year
1.10B
from 935.11M
Increased by 17.42%
EPS This Year
1.24
from 0.75
Increased by 65.24%
EPS Next Year
1.75
from 1.24
Increased by 41.40%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 971.1M | 1.2B | |||
| Avg | 935.1M | 1.1B | |||
| Low | 888.9M | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 43.3% | 26.9% | |||
| Avg | 38.0% | 17.4% | |||
| Low | 31.2% | 9.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.49 | 2.40 | |||
| Avg | 1.24 | 1.75 | |||
| Low | 0.80 | 1.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 98.8% | 94.0% | |||
| Avg | 65.2% | 41.4% | |||
| Low | 7.1% | -12.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.